Skip to content

Clinical study on the postoperative analgesic effect and cognitive function of paravertebral nerve block with dexmedetomidine combined with ropivacaine in patients with high nicotine dependence after thoracoscopy

Clinical study on the postoperative analgesic effect and cognitive function of paravertebral nerve block with dexmedetomidine combined with ropivacaine in patients with high nicotine dependence after thoracoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111529
Enrollment
Unknown
Registered
2025-11-01
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High nicotine dependence caused by long-term and heavy smoking

Interventions

The high-concentration dexmedetomidine and ropivacaine group (0.33% ropivacaine combined with 1 microgram/kg dexmedetomidine, 20 ml, DR2 group):Perform paravertebral nerve block using 0.33% ropivacain
Control group: Ropivacaine group (20 ml of 0.33% ropivacaine, R group):20 ml of 0.33% ropivacaine for paravertebral nerve block
low-dose dexmedetomidine and ropivacaine group (20 ml of 0.33% ropivacaine combined with 0.5 ug/kg dexmedetomidine, DR1 group):0.33% ropivacaine combined with 0.5 micrograms per kilogram dexmedetomidi

Sponsors

Liaocheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.ASA Grade II- III; 2. Patients aged 40 to 65 with high nicotine dependence (HND, Fagerstrom score >=6); 3. Master the operation of the PCA pump and the relevant postoperative scoring methods; 4. Patients scheduled to undergo thoracoscopy under general anesthesia with bronchotracheal intubation.

Exclusion criteria

Exclusion criteria: 1.Patients undergoing thoracoscopic surgery with a nicotine dependence score of Fagerstrom 30kg/m ²; 4. A history of ischemic heart disease within the last 6 months, with a heart rate of less than 50 beats per minute or second-degree or third-degree atrioventricular block; 5. Insufficiency of liver and kidney functions; 6. Neuropsychiatric disorders; 7. Long-term use of antihypertensive drugs or beta-adrenergic receptor blockers before the operation (more than 3 months); 8. Known to be allergic to the research drug; 9. Have a history of chronic pain and have been taking analgesic drugs for a long time (more than 3 months)

Design outcomes

Primary

MeasureTime frame
The dosage of sufentanil after surgery;

Secondary

MeasureTime frame
Patient demographic data and general intraoperative conditions;Perioperative hemodynamic changes;NRS score;LOS score;BCS score;FAS classification;

Countries

China

Contacts

Public ContactGao Xiujuan

Liaocheng People's Hospital

13082780369@163.com+86 13346259690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026